Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

222
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
311.7 316 319.7 317.5 315 Last
2004377 2425922 3300430 2451851 2070645 Volume
+0.03% +1.38% +1.17% -0.69% -0.79% Change
Company
Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of... 
Sector
Pharmaceuticals
Calendar
03/04 | 11:20amPresentation
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Financials ( DKK)
Sales 2015 105 323 M
EBIT 2015 43 421 M
Net income 2015 30 313 M
Finance 2015 12 450 M
Yield 2015 1,77%
Sales 2016 114 204 M
EBIT 2016 47 571 M
Net income 2016 36 789 M
Finance 2016 14 435 M
Yield 2016 2,17%
PER 2015 26,84
PER 2016 21,76
EV / Sales 2015 6,20x
EV / Sales 2016 5,70x
Capitalization 665 458 M
More Financials
Latest news on NOVO NORDISK A/S
03/02 NOVO NORDISK A/S : A/S: A/S - Share repurchase programme
03/02DJNovo Increases Price Range For its IT Services' IPO
02/26 NOVO NORDISK A/S : receives Health Canada approval for Saxenda® (liraglutide) fo..
02/25DJSanofi Wins Approval For New Insulin Drug
02/25DJSanofi Wins Approval For New Insulin Drug
02/24 NOVO NORDISK A/S : sets indicative price range for the contemplated IPO of NNIT ..
02/23 NOVO NORDISK A/S : BRIEF: Diabetes group to meet
02/23 NOVO NORDISK A/S : A/S : - Share repurchase programme
More news
Sector news Pharmaceuticals - NEC
01:57aDJToyota Taps First Foreign Vice President
01:47a BRISTOL MYERS SQUIBB : Announces Dividend
01:47a BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Supplemental Bi..
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF